Thymus Extract (generic name)

treats Burns, Urinary tract infection, Eczema, Cardiomyopathy, Dermatomyositis, Human papilloma virus, Psoriasis, Glaucoma, Alopecia, Arthritis...
Table of Contents
powered by healthline

Average Ratings


This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration ( Julie Conquer, PhD (RGB Consulting); Rebecca Bramwell, PharmD (Northeastern University); Ashley Brigham, PharmD (Northeastern University); Jessica Clubb, PharmD (Northeastern University); Thuy-Duong Le, PharmD (Oregon State University); Audrey Nealon, PharmD (Northeastern University); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Jen Woods, BS (Natural Standard Research Collaboration).


DISCLAIMER: Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to Selected references are listed below.

Akhmedov RM, Ochilov UB, Mirkhodzhaev IA, et al. [Prevention and treatment of postoperative complications of hepatic echinococcosis]. Med Parazitol.(Mosk) 2003;(2):18-21.

Aleksandrovskii IuA, Chekhonin VP. [Clinical and immunological studies in borderline mental disorders: problems and solutions]. Vestn.Ross.Akad.Med Nauk 1999;(7):12-15.

Arutiunian VM, Grigorian EG. [Effectiveness of using immunomodulators in combined treatment of patients with chronic gastritis and ulcer disease]. Klin.Med (Mosk) 2003;81(5):33-35.

Chien RN, Liaw YF. Thymalfasin for the treatment of chronic hepatitis B. Expert.Rev Anti.Infect.Ther 2004;2(1):9-16.

Christ HW. [Immunomodulating therapy of psoriasis vulgaris]. Med Klin (Munich) 10-15-1999;94 Suppl 3:90-92.

Jablonowska E, Tchorzewski H, Lewkowicz P, et al. Reactive oxygen intermediates and serum antioxidative system in patients with chronic C hepatitis treated with IFN-alpha and thymus factor X. Arch Immunol.Ther Exp (Warsz.) 2005;53(6):529-533.

Kevorkov NN, Gorovits GA, Bakhmet'ev SA. [Likopid in the complex immunomodulating treatment of patients with sarcoidosis of the lung and intrathoracic lymph nodes]. Ter.Arkh. 2002;74(3):55-58.

Liberati AM, Ballatori E, Fizzotti M, et al. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission. Cancer Immunol.Immunother. 1988;26(1):87-93.

Mustacchi G, Pavesi L, Milani S, et al. High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial. Anticancer Res 1994;14(2B):617-619.

Nazarov IP, Popov AA, Protopopov BV, et al. [Ways of correcting immunodeficiency at different stages of burns with the aim of prevention and treatment of sepsis]. Anesteziol.Reanimatol. 1999;(1):63-68.

Popiela T, Kulig J, Klek S, et al. Enzyme therapy in patients with advanced colorectal cancer. Przegl.Lek. 2000;57 Suppl 5:138-139.

Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 11-15-1998;129(10):797-800.

Romeo F, Arcoria D, Palmisano L, et al. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial. Arzneimittelforschung 1985;35(8):1317-1322.

Salvati F, Pallotta G, Antilli A, et al. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial]. G Ital Chemioter. 1984;31(1-2):185-189.

Sanchiz F, Milla A. A randomised study comparing granulocyte-colony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy. Eur.J Cancer 1996;32A(1):52-56.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Page: < Back 1 2 3 4 5
Licensed from
Top of page
General Drug Tools
General Drug Tools
Health Management
Health Management Programs
Tools for
Healthy Living
Tools for Healthy Living